T. Rowe Price Investment Management »

Summit Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $33k 1.9k 17.62
2025-09-30 $2.0k 68 29.41

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Alphabet Comm Stk (GOOGL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Becton Dickinson & Co Comm Stk (BDX)
Yum Brands Comm Stk (YUM)
Cencora Comm Stk (COR)
Abbott Labs Comm Stk (ABT)
Centerpoint Energy Comm Stk (CNP)
Revvity Comm Stk (RVTY)
Nisource Comm Stk (NI)
Meta Platforms Comm Stk (META)
Broadcom Comm Stk (AVGO)

View all positions for T. Rowe Price Investment Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Geode Capital Management
Polymer Capital Management
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics